Short Interest in Daxor Co. (NASDAQ:DXR) Declines By 13.6%

Daxor Co. (NASDAQ:DXR) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 7,000 shares, a decline of 13.6% from the March 15th total of 8,100 shares. Based on an average daily volume of 2,700 shares, the short-interest ratio is presently 2.6 days. Currently, 0.4% of the company’s shares are sold short.

Daxor Price Performance

Shares of Daxor stock traded up $0.05 on Tuesday, reaching $9.55. The company had a trading volume of 577 shares, compared to its average volume of 3,441. The firm’s 50 day moving average price is $8.54 and its two-hundred day moving average price is $8.57. Daxor has a 52-week low of $7.11 and a 52-week high of $13.13.

Daxor Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.